Uwe E Reinhardt - Net Worth and Insider Trading

Uwe E Reinhardt Net Worth

The estimated net worth of Uwe E Reinhardt is at least $3 Million dollars as of 2024-11-12. Uwe E Reinhardt is the Director of Boston Scientific Corp and owns about 37,000 shares of Boston Scientific Corp (BSX) stock worth over $3 Million. Details can be seen in Uwe E Reinhardt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Uwe E Reinhardt has not made any transactions after 2006-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Uwe E Reinhardt

To

Uwe E Reinhardt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Uwe E Reinhardt owns 5 companies in total, including Tekla World Healthcare Fund (THW) , Boston Scientific Corp (BSX) , and Tekla Healthcare Opportunities Fund (THQ) among others .

Click here to see the complete history of Uwe E Reinhardt’s form 4 insider trades.

Insider Ownership Summary of Uwe E Reinhardt

Ticker Comapny Transaction Date Type of Owner
THW Tekla World Healthcare Fund 2015-06-25 director
BSX Boston Scientific Corp 2006-02-28 director
THQ Tekla Healthcare Opportunities Fund 2014-07-28 director
LIMIT LIMIT 2014-06-24 director
LIMIT LIMIT 2014-06-24 director

Uwe E Reinhardt Latest Holdings Summary

Uwe E Reinhardt currently owns a total of 1 stock. Uwe E Reinhardt owns 37,000 shares of Boston Scientific Corp (BSX) as of February 28, 2006, with a value of $3 Million.

Latest Holdings of Uwe E Reinhardt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BSX Boston Scientific Corp 2006-02-28 37,000 88.85 3,287,450

Holding Weightings of Uwe E Reinhardt


Uwe E Reinhardt Form 4 Trading Tracker

According to the SEC Form 4 filings, Uwe E Reinhardt has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the acquisition of 5,000 shares on February 28, 2006, which cost Uwe E Reinhardt around $122,250.

Insider Trading History of Uwe E Reinhardt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Uwe E Reinhardt Trading Performance

GuruFocus tracks the stock performance after each of Uwe E Reinhardt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Uwe E Reinhardt is -6.57%. GuruFocus also compares Uwe E Reinhardt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Uwe E Reinhardt within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Uwe E Reinhardt's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Uwe E Reinhardt

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.46 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.37 LIMIT LIMIT LIMIT LIMIT LIMIT

Uwe E Reinhardt Ownership Network

Ownership Network List of Uwe E Reinhardt

No Data

Ownership Network Relation of Uwe E Reinhardt

Insider Network Chart

Uwe E Reinhardt Owned Company Details

What does Tekla World Healthcare Fund do?

Who are the key executives at Tekla World Healthcare Fund?

Uwe E Reinhardt is the director of Tekla World Healthcare Fund. Other key executives at Tekla World Healthcare Fund include Vice President Alan R Goodson , other: Director of Adviser Jaclyn Marie Matsick , and other: Director of Adviser Marika Tooze .

Tekla World Healthcare Fund (THW) Insider Trades Summary

Over the past 18 months, Uwe E Reinhardt made no insider transaction in Tekla World Healthcare Fund (THW). Other recent insider transactions involving Tekla World Healthcare Fund (THW) include a net purchase of 1,000 shares made by Rose Dimartino , a net purchase of 1,000 shares made by Bill Maher , and a net purchase of 200 shares made by Kathleen Goetz .

In summary, during the past 3 months, insiders sold 0 shares of Tekla World Healthcare Fund (THW) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 0 shares of Tekla World Healthcare Fund (THW) were sold and 2,200 shares were bought by its insiders, resulting in a net purchase of 2,200 shares.

Tekla World Healthcare Fund (THW)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tekla World Healthcare Fund Insider Transactions

No Available Data

Uwe E Reinhardt Mailing Address

Above is the net worth, insider trading, and ownership report for Uwe E Reinhardt. You might contact Uwe E Reinhardt via mailing address: C/o Boston Scientific Corp, 300 Boston Scientific Way, Marlborough Ma 01752-1234.